“Dose Adjustment Patterns in the Open-Label Extension Arms of Three Phase 3 Trials of Certolizumab Pegol in Psoriasis: CIMPASI-1, CIMPASI-2, and CIMPACT”. SKIN The Journal of Cutaneous Medicine 4, no. 6 (October 27, 2020): s85. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/1118.